Haring-Smith Whitney 的 Form 4 申報
Envoy Medical, Inc.（COCH），2023/10/3 申報
- 申報編號
- 0001062993-23-018937
- 申報時間
- 2023/10/3 21:58 ET
- 交易日
- 2023/9/29
- 申報延遲
- 4 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 2 筆非衍生性交易、5 筆衍生性交易。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Haring-Smith WhitneyCIK 0001846535 | 董事、持股 10% 以上大股東 |
| Anzu SPAC GP I LLCCIK 0001846378 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/9/29 | Class A Common Stock, par value $0.0001 per share | P買進取得 | +869,565 | $10.00 | +$10,000,000 | 1,000,000 | 間接 | |
| 2023/9/29 | Class A Common Stock, par value $0.0001 per share | J其他取得 | +2,173,913 | $0.00F8 | $0 | 2,500,000 | 直接 | |
| 2023/9/29 | Class A Common Stock, par value $0.0001 per share | D交回公司處分 | −5,510,000 | $0.00F9 | $0 | 4,990,000 | 直接 | |
| 2023/9/29 | Class A Common Stock, par value $0.001 per share | J其他處分 | −2,500,000 | $0.00F8 | $0 | 2,490,000 | 直接 | |
| 2023/9/29 | Class A Common Stock, par value $0.0001 per share | C轉換處分 | −2,490,000 | $0.00F10 | $0 | 0 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
These shares were issued in connection with the automatic conversion of an equal number of shares of Class B Common Stock, par value $0.0001 per share ("Class B Common Stock"), which converted to Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), upon the closing (the "Closing") of the business combination between Anzu Special Acquisition Corp. I and Envoy Medical Corporation (the "Business Combination").... (continued)
表 I 有 1 筆交易的價格引用這則附註。
- F2
(Continued from footnote 1) ...Prior to the Closing, Anzu SPAC GP I LLC (the "Sponsor") beneficially owned 10,500,000 shares of Class B Common Stock. In connection with the Closing, the Sponsor forfeited 5,510,000 shares of Class B Common Stock and exchanged 2,500,000 shares of Class B Common Stock for an equal number of shares of Series A Preferred Stock, par value $0.0001 ("Series A Preferred Stock") in a private exchange offer. The Issuer's remaining 2,490,000 shares of Class B Common Stock automatically converted to an equal number of shares of Class A Common Stock upon the Closing.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The Sponsor transferred an aggregate of 490,000 shares of Class A Common Stock to various third parties pursuant to (i) the extension support agreements between the Issuer, the Sponsor and several unaffiliated third parties and (ii) the side letter agreements between the Sponsor and certain institutional investors.
表 I 有 1 筆交易的價格引用這則附註。
- F8
On September 29, 2023, in connection with the Closing, an aggregate of 2,500,000 shares of Series A Preferred Stock were issued to the Sponsor in exchange for 2,500,000 shares of Class B Common Stock held by the Sponsor in a private exchange offer.
表 II 有 2 筆交易的價格引用這則附註。
- F9
On September 29, 2023, in connection with the Closing, the Sponsor forfeited 5,510,000 shares of Class B Common Stock.
表 II 有 1 筆交易的價格引用這則附註。
- F10
On September 29, 2023, in connection with the Closing, each share of Class B Common Stock automatically converted into one share of Class A Common Stock.
表 II 有 1 筆交易的價格引用這則附註。